Cresco Labs Inc.
CL
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -5.28% | -6.55% | -7.28% | -8.35% | -8.93% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.28% | -6.55% | -7.28% | -8.35% | -8.93% |
| Cost of Revenue | -15.92% | -16.28% | -10.20% | -6.20% | 5.23% |
| Gross Profit | 8.18% | 5.98% | -3.83% | -10.75% | -22.18% |
| SG&A Expenses | -21.68% | -23.26% | -21.76% | -16.36% | -3.89% |
| Depreciation & Amortization | 27.78% | 39.28% | 26.19% | 18.91% | 7.70% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.92% | -17.60% | -13.86% | -9.63% | -0.64% |
| Operating Income | 238.12% | 274.20% | 110.36% | 8.15% | -66.82% |
| Income Before Tax | 99.73% | 27.78% | 12.47% | -15.76% | -861.49% |
| Income Tax Expenses | 13.22% | -58.43% | -58.83% | -62.95% | -45.03% |
| Earnings from Continuing Operations | 84.66% | 36.58% | 29.95% | 16.67% | -675.16% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -143.99% | -149.69% | -106.14% | 14.07% | 241.17% |
| Net Income | 80.14% | 26.21% | 26.60% | 17.22% | -418.77% |
| EBIT | 238.12% | 274.20% | 110.36% | 8.15% | -66.82% |
| EBITDA | 100.37% | 109.49% | 60.11% | 13.85% | -39.32% |
| EPS Basic | 81.89% | 33.93% | 33.10% | 23.89% | -380.61% |
| Normalized Basic EPS | -199.09% | -3,345.45% | 648.61% | -1.23% | -0.90% |
| EPS Diluted | 81.89% | 33.93% | 33.10% | 23.89% | -380.61% |
| Normalized Diluted EPS | -199.09% | -3,345.45% | 648.61% | -1.23% | -0.90% |
| Average Basic Shares Outstanding | 9.13% | 11.57% | 10.57% | 8.58% | 7.50% |
| Average Diluted Shares Outstanding | 9.13% | 11.57% | 10.57% | 8.58% | 7.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
